Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease
Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease
Recruiting · NCT06343792 · Registry updated 2025-11-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease | Steroid Refractory GVHD | Recruiting | Phase 2 | 2025-11-24 | NCT06343792 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CTI Clinical Trial and Consulting Services | 4 |
| ReAlta Life Sciences, Inc. | 3 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Site 1068 | St Louis | United States | 1 |
| Site 1091 | Duarte | United States | 1 |
| Site 1100 | Cincinnati | United States | 1 |
| Site 1318 | Atlanta | United States | 1 |
| Site 1343 | Los Angeles | United States | 1 |
| Site 1382 | Columbus | United States | 1 |
| Site 3101 | Seville | Spain | 1 |
| Site 3101 | Seville | Spain | 1 |
| Site 3227 | Salamanca | Spain | 1 |
| Site 3242 | Freiburg im Breisgau | Germany | 1 |
| Site 3360 | Madrid | Spain | 1 |